Skip to main content
. 2014 Jun 19;111(2):241–248. doi: 10.1038/bjc.2014.346

Table 5. Adverse events of special interest with bevacizumab.

Adverse events, n (%) Any grade Grade 1 Grade 2 Grade 3 Grade 4
Hypertension
8 (12)
2 (3)
5 (7)
1 (1)
0
Ischaemic event
1 (1)
0
0
1 (1)
0
Angina
1 (1)
0
0
1 (1)
0
Epistaxis
9 (13)
8 (12)
1 (1)
0
0
Bleeding gums
1 (1)
1 (1)
0
0
0
Bleeding from colostomy
1 (1)
1 (1)
0
0
0
Rectal bleeding
1 (1)
1 (1)
0
0
0
Bloody stool
1 (1)
0
1 (1)
0
0
Proteinuria
8 (12)
2 (3)
5 (7)
1 (1)
0
Deep-vein thrombosis
6 (9)
0
2 (3)
4 (6)
0
Pulmonary thromboembolism
4 (6)
0
1 (1)
2 (3)
1 (1)
Gastrointestinal perforation 1 (1) 0 0 1 (1) 0